84年鼠女哪年财运最旺,857comvvv色九欧美激情|85PO_87国产精品欲av国产av资源

[1]林潔,范展彪,劉獻(xiàn)祥.基于數(shù)據(jù)挖掘技術(shù)探討陳可冀《清宮配方集成》中治療骨關(guān)節(jié)炎組方的用藥規(guī)律[J].中醫(yī)正骨,2017,29(11):15-19,25.
 LIN Jie,FAN Zhanbiao,LIU Xianxiang.Study on medication rule extracted from prescription for treatment of osteoarthritis in Royal Formulary of Qing Dynasty written by Chen Keji based on data mining techniques[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(11):15-19,25.
點(diǎn)擊復(fù)制

基于數(shù)據(jù)挖掘技術(shù)探討陳可冀《清宮配方集成》中治療骨關(guān)節(jié)炎組方的用藥規(guī)律()
分享到:

《中醫(yī)正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第29卷
期數(shù):
2017年11期
頁(yè)碼:
15-19,25
欄目:
基礎(chǔ)研究
出版日期:
2017-11-20

文章信息/Info

Title:
Study on medication rule extracted from prescription for treatment of osteoarthritis in Royal Formulary of Qing Dynasty written by Chen Keji based on data mining techniques
作者:
林潔范展彪劉獻(xiàn)祥
福建中醫(yī)藥大學(xué),福建 福州 350122
Author(s):
LIN JieFAN ZhanbiaoLIU Xianxiang
Fujian University of Traditional Chinese Medicine,Fuzhou 350122,Fujian,China
關(guān)鍵詞:
骨關(guān)節(jié)炎 中醫(yī)藥學(xué)文獻(xiàn) 組方原則 數(shù)據(jù)挖掘 聚類分析
Keywords:
Key words osteoarthritis med pharmacol literature TCM formula composing principles data mining cluster analysis
摘要:
目的:探討陳可冀《清宮配方集成》中治療骨關(guān)節(jié)炎組方的用藥規(guī)律。方法:從《清宮配方集成》中篩選出124首治療骨關(guān)節(jié)炎的方劑,利用Access軟件建立數(shù)據(jù)庫(kù),分析每味藥物的出現(xiàn)頻次及按功效、性味、歸經(jīng)分類后藥物的累積出現(xiàn)頻次; 基于中醫(yī)傳承輔助平臺(tái)軟件(V2.5)對(duì)所選數(shù)據(jù)采用關(guān)聯(lián)分析中的Apriori算法分析常見組方規(guī)律,采用聚類分析法演化出核心組方及新方組合。結(jié)果:124首方劑中出現(xiàn)頻次居于前10位的中藥依次為當(dāng)歸、牛膝、防風(fēng)、獨(dú)活、羌活、杜仲、乳香、沒(méi)藥、熟地黃、木瓜,按功效分類后出現(xiàn)頻次居于前5位的依次為祛風(fēng)濕藥、活血化瘀藥、補(bǔ)肝腎藥、強(qiáng)筋骨藥、解表藥,藥性以溫、平多見,藥味以辛、苦、甘多見,歸經(jīng)以肝、腎、脾經(jīng)為主; 分析出常用中藥組合25個(gè),挖掘出24個(gè)核心組合、12個(gè)新方組合。結(jié)論:陳可冀《清宮配方集成》中治療骨關(guān)節(jié)炎的中藥組方,多用性溫、平,味辛、苦、甘,入肝、腎、脾經(jīng)的中藥; 其功效多以祛風(fēng)除濕、活血化瘀、補(bǔ)肝腎、強(qiáng)筋骨為主; 多以獨(dú)活寄生湯為核心進(jìn)行加減組方; 核心組方和新方組合可為臨床遣方用藥提供參考,但其療效有待進(jìn)一步研究。
Abstract:
ABSTRACT Objective:To explore the medication rule extracted from prescription for treatment of osteoarthritis in Royal Formulary of Qing Dynasty written by Chen Keji.Methods:One hundred and twenty-four prescriptions for treatment of OA were searched out from Royal Formulary of Qing Dynasty,and the database was established by using Access sorftware.The occurrence frequency of each drug and the accumulated frequency of drugs that were classificated according to function,property and flavour and meridian distribution were analyzed repectively.Based on the software of TCM inheritance auxiliary platform(V2.5),the common medication rules were searched out through analyzing the selected data by using Apriori algorithm in association analysis and the core prescription and combination of new prescription were obtained by using cluster analysis.Results:In 124 prescriptions,the top 10 Chinese drugs with high occurrence frequency included Chinese angelica,achyranthes bidentata,saposhnikovia divaricata,heracleum,notopterygium,eucommia ulmoides,frankincense,myrrh,prepared rehmannia root and pawpaw.According to the effect classification,the top 5 Chinese drugs with high occurrence frequency included antirheumatic Chinese drugs and Chinese drugs for blood-activating and stasis-resolving,reinforcing liver-kidney,strengthening bones and muscles and relieving exterior syndrome.The drug properties presented mainly with warm and normal; and the drug flavours presented mainly with pungent,bitter and sweet; and the meridian distributions presented mainly with liver meridian,kidney meridian and spleen meridian.Twenty five common traditional Chinese medicine(TCM)combination,24 core TCM combination and 12 new TCM combination were obtained.Conclusion:In TCM combination for treatment of osteoarthritis in Royal Formulary of Qing Dynasty written by Chen Keji,the drug properties presented mainly with warm and normal; and the drug flavours presented mainly with pungent,bitter and sweet; and the meridian distributions presented mainly with liver meridian,kidney meridian and spleen meridian; and the pharmacological actions presented mainly with antirheumatic,blood-activating and stasis-resolving,reinforcing liver-kidney,strengthening bones and muscles.Duhuo Jisheng Tang(獨(dú)活寄生湯)was usually used as the core of TCM combination.The core TCM combination and new TCM combination can provide reference for clinical medication,while their curative effects need to be further studied.

參考文獻(xiàn)/References:

[1] OLIVERIA SA,FELSON DT,REED JI,et al.Incidence of symptomatic hand,hip,and knee osteoarthritis among patients in a health maintenance organization[J].Arthritis Rheum,1995,38(8):1134-1141.
[2] 國(guó)家中醫(yī)藥管理局.中醫(yī)病證診斷療效標(biāo)準(zhǔn)[M].南京:南京大學(xué)出版社,1994:30-31.
[3] 吳明霞,張福強(qiáng),劉獻(xiàn)祥.福州市膝關(guān)節(jié)骨性關(guān)節(jié)炎的中醫(yī)證候分布探討[J].福建中醫(yī)學(xué)院學(xué)報(bào),2008,18(3):37-39.
[4] 胡彬,謝興文,李寧,等.膝骨關(guān)節(jié)炎證型分布:二步聚類分析與對(duì)應(yīng)分析法調(diào)查的比較[J].中國(guó)組織工程研究,2014,18(11):1799-1804.
[5] 葛文杰,蔡建平,張賢,等.213例膝骨關(guān)節(jié)炎患者中醫(yī)癥候規(guī)律分析[J].四川中醫(yī),2017,35(1):57-59.
[6] 劉獻(xiàn)祥.中醫(yī)藥治療膝骨性關(guān)節(jié)炎的研究現(xiàn)狀[J].中醫(yī)正骨,2012,24(1):3-7.
[7] 陳可冀.清宮配方集成[M].北京:北京大學(xué)醫(yī)學(xué)出版社,2013:1-527.
[8] 劉廣,孫宏.論中醫(yī)學(xué)數(shù)據(jù)挖掘的數(shù)據(jù)預(yù)處理[J].遼寧中醫(yī)藥大學(xué)學(xué)報(bào),2012,14(5):146-147.
[9] 高學(xué)敏.中藥學(xué)[M].2版.北京:中國(guó)中醫(yī)藥出版社,2007:51-502.
[10] 李健,盧朋,唐仕歡,等.基于中醫(yī)傳承輔助系統(tǒng)的治療肺癰方劑組方規(guī)律分析[J].中國(guó)實(shí)驗(yàn)方劑學(xué)雜志,2012,18(2):254-257.
[11] 劉獻(xiàn)祥.基于陳可冀學(xué)術(shù)思想之骨性關(guān)節(jié)炎研究[J].康復(fù)學(xué)報(bào),2016,26(1):2-5.
[12] 鄭文偉,翁霞萍,黃綏心,等.獨(dú)活寄生湯對(duì)骨關(guān)節(jié)炎軟骨退變的影響及其作用機(jī)制[J].中醫(yī)正骨,2017,29(7):5-11.
[13] 鄭春松,徐筱杰,葉蕻芝,等.青風(fēng)藤治療骨性關(guān)節(jié)炎藥效物質(zhì)基礎(chǔ)多靶導(dǎo)向作用的計(jì)算機(jī)模擬研究[J].中國(guó)中西醫(yī)結(jié)合雜志,2012,32(3):375-379.
[14] 梁浩東,潘建科,洪坤豪,等.劉軍運(yùn)用嶺南特色藥物治療膝骨性關(guān)節(jié)炎經(jīng)驗(yàn)探析[J].遼寧中醫(yī)雜志,2016,43(6):1152-1154.
[15] 付長(zhǎng)龍,劉獻(xiàn)祥.中藥多糖干預(yù)骨關(guān)節(jié)炎作用機(jī)制探討[J].風(fēng)濕病與關(guān)節(jié)炎,2015,4(3):36-39.

相似文獻(xiàn)/References:

[1]孟維娜,明立功,王新德,等.關(guān)節(jié)鏡下清理聯(lián)合腓骨近1/3段截骨治療膝骨關(guān)節(jié)炎[J].中醫(yī)正骨,2015,27(11):40.
[2]明立功,孟維娜,王新德,等.腓骨近端截骨治療內(nèi)側(cè)間室膝骨關(guān)節(jié)炎的近期療效觀察[J].中醫(yī)正骨,2015,27(10):25.
[3]張杰,王人彥,張玉柱.膝骨關(guān)節(jié)炎的治療進(jìn)展[J].中醫(yī)正骨,2015,27(10):68.
[4]梁朝,蔡靜怡,閆立,等.針刀療法改善膝骨關(guān)節(jié)炎早期疼痛癥狀的療效評(píng)價(jià)[J].中醫(yī)正骨,2015,27(09):9.
 LIANG Zhao,CAI Jingyi,YAN Li,et al.Evaluation of the curative effect of needle-knife therapy for relieving knee pain in patients with early knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(11):9.
[5]王建武,黨建軍,李強(qiáng),等.四聯(lián)療法治療膝骨關(guān)節(jié)炎[J].中醫(yī)正骨,2015,27(08):44.
[6]劉紅娟,郭會(huì)利,郭樹農(nóng).云克聯(lián)合中藥治療膝骨關(guān)節(jié)炎的護(hù)理[J].中醫(yī)正骨,2015,27(08):75.
[7]陳衛(wèi)衡.探索建立系統(tǒng)的膝骨關(guān)節(jié)炎中醫(yī)臨床科研范式 和理論體系[J].中醫(yī)正骨,2015,27(07):1.
[8]鄭春松,葉蕻芝,李西海,等.透骨消痛膠囊中補(bǔ)腎柔肝藥和活血祛風(fēng)藥治療 骨關(guān)節(jié)炎作用方式的計(jì)算機(jī)模擬比較[J].中醫(yī)正骨,2015,27(07):6.
 ZHENG Chunsong,YE Hongzhi,LI Xihai,et al.Comparison of the mode of action of Bushen Rougan(補(bǔ)腎柔肝)drugs versus Huoxue Qufeng(活血祛風(fēng))drugs contained in Tougu Xiaotong Jiaonang(透骨消痛膠囊)for the treatment of osteoarthritis:A computer simulation study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(11):6.
[9]帥波,沈霖,楊艷萍,等.加味青娥丸治療膝骨關(guān)節(jié)炎的作用機(jī)制研究[J].中醫(yī)正骨,2015,27(07):15.
 SHUAI Bo,SHEN Lin,YANG Yanping,et al.Study on the mechanism of action of Jiawei Qing'e Wan(加味青娥丸)for the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(11):15.
[10]梅其杰,袁長(zhǎng)深,段戡,等.壯藥骨痹方燙熨聯(lián)合運(yùn)動(dòng)療法治療膝骨關(guān)節(jié)炎的臨床研究[J].中醫(yī)正骨,2015,27(07):27.
 MEI Qijie,YUAN Changshen,DUAN Kan,et al.Clinical study of the curative effect of hot compressing and rubbing with packet of Gubi Fang(骨痹方)combined with exercise therapy in the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(11):27.

備注/Memo

備注/Memo:
基金項(xiàng)目:福建省高等學(xué)校新世紀(jì)優(yōu)秀人才支持計(jì)劃項(xiàng)目(閩教科〔2017〕52號(hào)); 陳可冀中西醫(yī)結(jié)合發(fā)展基金項(xiàng)目(CKJ2017002) 通訊作者:劉獻(xiàn)祥 E-mail:[email protected]
更新日期/Last Update: 2018-04-02